Skip to main content

Peer Review reports

From: Pembrolizumab-induced myasthenia gravis-like disorder, ocular myositis, and hepatitis: a case report

Original Submission
19 Mar 2020 Submitted Original manuscript
25 Mar 2020 Author responded Author comments - Chia-Yi Tian
Resubmission - Version 2
25 Mar 2020 Submitted Manuscript version 2
21 Apr 2020 Reviewed Reviewer Report - Teodora Alexa - Stratulat
2 May 2020 Reviewed Reviewer Report - Hamouda Boussen
3 May 2020 Reviewed Reviewer Report - Vineet Kwatra
20 May 2020 Author responded Author comments - Chia-Yi Tian
Resubmission - Version 3
20 May 2020 Submitted Manuscript version 3
25 May 2020 Reviewed Reviewer Report - Hamouda Boussen
8 Jun 2020 Reviewed Reviewer Report - Teodora Alexa - Stratulat
17 Jun 2020 Author responded Author comments - Chia-Yi Tian
Resubmission - Version 4
17 Jun 2020 Submitted Manuscript version 4
29 Jun 2020 Reviewed Reviewer Report - Teodora Alexa - Stratulat
5 Aug 2020 Author responded Author comments - Chia-Yi Tian
Resubmission - Version 5
5 Aug 2020 Submitted Manuscript version 5
26 Dec 2020 Reviewed Reviewer Report - Teodora Alexa - Stratulat
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
8 Feb 2021 Editorially accepted
30 Apr 2021 Article published 10.1186/s13256-021-02722-8

You can find further information about peer review here.

Back to article page